Combination therapy of pegylated interferon alpha 2a and ruxolitinib in myelofibrosis: a case report

被引：0
|
作者：
Hindilerden, F. [1 ]
Demiriz, I. [1 ]
机构：
[1] SBU Bakirkoy Dr Sadi Konuk Egitim & Arastirma Has, Hematol Klin, Istanbul, Turkey
来源：
LEUKEMIA RESEARCH | 2019年 / 85卷
关键词：
D O I：
10.1016/S0145-2126(19)30319-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP-24
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [31] Unilateral sensori-neural hearing loss induced by pegylated interferon α2a: a case report
    Kohla, Mohamed
    Gish, Robert
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 236 - 236
  • [32] Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
    Popescu, Cristina
    Arama, Victoria
    Gliga, Smaranda
    BMC GASTROENTEROLOGY, 2011, 11
  • [33] Unilateral Sensori-Neural Hearing Loss Induced by Pegylated Interferon α2a: A Case Report
    Kohla, M.
    Gish, R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : E113 - E113
  • [34] Outcomes Are Similar for Combination Interferon and Ruxolitinib Versus Ruxolitinib in Myelofibrosis: A Propensity-Score Matched Study
    Erdos, Katie
    Alshareef, Aya
    Silver, Richard T.
    Scandura, Joseph M.
    Abu-Zeinah, Ghaith
    BLOOD, 2024, 144 : 1784 - 1785
  • [35] Pegylated interferon 2a and ruxolitinib induce a high rate of oral complications among patients with myeloproliferative neoplasms
    Orliaguet, Marie
    Boisrame, Sylvie
    Eveillard, Jean-Richard
    Pan-Petesch, Brigitte
    Couturier, Marie-Anne
    Rebiere, Vincent
    Guillerm, Gaelle
    Le Bousse-Kerdiles, Marie-Caroline
    Misery, Laurent
    Lippert, Eric
    Ianotto, Jean-Christophe
    EJHAEM, 2020, 1 (01): : 350 - 352
  • [36] Pegylated Interferon Alpha-2b Associated Cutaneous Necrosis: A Case Report
    Guner, Rahmet
    Yapar, Derya
    Sarici, Murat
    Tasyaran, Mehmet Akin
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2010, 16 (02): : 77 - 79
  • [37] Development of Sarcoidosis Following Completion of Treatment for Hepatitis C with Pegylated Interferon-alpha 2a and Ribavirin: A Case Report and Literature Review
    Gayet, Alberic-Rembrandt
    Plaisance, Patrick
    Bergmann, Jean-Francois
    Mouly, Stephane
    CLINICAL MEDICINE & RESEARCH, 2010, 8 (3-4) : 163 - 167
  • [38] Studies of therapy with thymosin α1 in combination with pegylated interferon α2a and ribavirin in nonresponder patients with chronic hepatitis C
    Camerini, Roberto
    Ciancio, Alessia
    De Rosa, Alfonso
    Rizzetto, Mario
    THYMOSINS IN HEALTH AND DISEASE: FIRST INTERNATIONAL SYMPOSIUM, 2007, 1112 : 368 - 374
  • [39] Pegylated interferon α-2a and ribavirin combination therapy in HCV liver transplant recipients.: Experience of 7 cases
    Iacob, Speranta
    Gheorghe, Liana
    Hrehoret, Doina
    Becheanu, Gabriel
    Herlea, Vlad
    Popescu, Irinel
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2008, 17 (02) : 165 - 172
  • [40] Injection site with generalized rash caused by pegylated interferon alpha 2a injection
    Kawada, K
    Maeda, N
    Kobayashi, S
    Sowa, J
    Tsuruta, D
    Kawada, N
    DERMATOLOGY, 2006, 212 (01) : 82 - 83
12345